In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Second-generation (2G) chimeric antigen receptors (CARs) targeting CD19 are highly active against B cell malignancies, but it is unknown whether any of the costimulatory domains incorporated in the CAR have superior activity to others. Because CD28 and 4-1BB signaling activate different pathways, co...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Ther
Main Authors: Ramos, Carlos A., Rouce, Rayne, Robertson, Catherine S., Reyna, Amy, Narala, Neeharika, Vyas, Gayatri, Mehta, Birju, Zhang, Huimin, Dakhova, Olga, Carrum, George, Kamble, Rammurti T., Gee, Adrian P., Mei, Zhuyong, Wu, Meng-Fen, Liu, Hao, Grilley, Bambi, Rooney, Cliona M., Heslop, Helen E., Brenner, Malcolm K., Savoldo, Barbara, Dotti, Gianpietro
格式: Artigo
語言:Inglês
出版: American Society of Gene & Cell Therapy 2018
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277484/
https://ncbi.nlm.nih.gov/pubmed/30309819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.09.009
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍